Valeant Pharmaceuticals

  • Quality Associate II, Product Release & Receiving Inspection

    Job Location US-NY-Rochester
    Job ID
    10613
    Pos. Category
    Operations
    Pos. Type
    Full Time
  • Overview

    Work Schedule:  A Shift - 12 hour Shift (6:00 am - 6:00 pm) including every other weekend and overtime.

     

    The Quality Associate II ensures product compliance through the inspection of incoming materials and final product.

    Responsibilities

    • Inspect and measure incoming materials and components using calibrated measuring instruments.
    • Notify chemistry for receipts that require lab analysis.
    • Disposition incoming products and label containers to reflect the inspection and test results in accordance with procedures.
    • Document inspection results and maintain filing system.
    • Review sterilization records/documentation and approve the release of autoclave cycles.
    • Interpret procedures and specifications to release acceptable product.
    • Review final product quality records and verify counts for evidence of compliance to the quality system transactions to release accepted incoming materials, components and outgoing products.
    • Place and remove lots on hold through interaction with purchasing, manufacturing and quality.
    • Maintain records in accordance with the Record Retention Policies.  

    Qualifications

    • High School diploma or equivalent is required.
    • Must be able to read, write and speak English and possess basic math skills.
    • Demonstrated ability to work in a team environment.
    • Excellent interpersonal skills.
    • Ability to meet physical requirements (medical clearance is required)
    • Shift flexibility and ability to work overtime is required.

    EXPERIENCE

    3+ years’ experience in a GMP environment preferred.  Knowledge of Excel, Word.

     

    TSA background check and certified cargo screener training required within 30 days.

     

     

     

    Options

    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed